Cocrystal Pharma, Inc. (COCP) › Shareholders' EquityCocrystal Pharma, Inc. (COCP) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2009: -$226.4K2010: -$589.2K2011: -$2.77M2012: -$5.01M2013: -$8.83M2014: $6.65M2015: $167.59M2016: $102.32M2017: $105.40M2018: $66.89M2019: $25.71M2020: $52.51M2021: $77.55M2022: $39.60M2023: $26.38M2024: $9.52M2025: $6.33M$6.33M2009Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$6.33M-33.5%2024$9.52M-63.9%2023$26.38M-33.4%2022$39.60M-48.9%2021$77.55M+47.7%2020$52.51M+104.2%2019$25.71M-61.6%2018$66.89M-36.5%2017$105.40M+3.0%2016$102.32M-38.9%2015$167.59M+2419.8%2014$6.65M+175.3%2013-$8.83M-76.4%2012-$5.01M-80.9%2011-$2.77M-370.0%2010-$589.2K-160.3%2009-$226.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share